Bilateral adrenal uptake of
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
03 06 2022
03 06 2022
Historique:
received:
10
01
2022
accepted:
20
05
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
9
6
2022
Statut:
epublish
Résumé
Cases in which bilateral adrenal
Identifiants
pubmed: 35660748
doi: 10.1038/s41598-022-13132-1
pii: 10.1038/s41598-022-13132-1
pmc: PMC9166707
doi:
Substances chimiques
Iodine Radioisotopes
0
3-Iodobenzylguanidine
35MRW7B4AD
Metanephrine
5001-33-2
Iodine-123
8YWR746RPQ
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9276Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022. The Author(s).
Références
Henry, J. P. et al. The catecholamine transporter of adrenal medulla chromaffin granules. Ann N Y Acad Sci. 733, 185–192 (1994).
doi: 10.1111/j.1749-6632.1994.tb17268.x
Lenders, J. W. et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 99, 1915–1942 (2014).
doi: 10.1210/jc.2014-1498
Wiseman, G. A. et al. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J. Nucl. Med. 50, 1448–1454 (2009).
doi: 10.2967/jnumed.108.058701
King, K. S. et al. Functional imaging of SDHx-related head and neck paragangliomas: Comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. J. Clin. Endocrinol. Metab. 96, 2779–2785 (2011).
doi: 10.1210/jc.2011-0333
Dell’Aversana, S. et al. Integrated imaging characterization of adrenal adenoma: False-positive metaiodobenzylguanidine (MIBG) findings of adrenal scintigraphy. Pol J Radiol. 82, 422–425 (2017).
doi: 10.12659/PJR.901853
Jung, H. S. et al. False positive radioiodinated metaiodobenzylguanidine ((123)I-MIBG) uptake in undifferentiated adrenal malignant tumor. Case Rep. Oncol. Med. 2015, 164280 (2015).
pubmed: 25918656
pmcid: 4396541
Bravo, E. L. Pheochromocytoma: Current perspectives in the pathogenesis, diagnosis, and management. Arq. Bras. Endocrinol. Metab. 48, 746–750 (2004).
doi: 10.1590/S0004-27302004000500021
Goldstein, R. E. et al. Clinical experience over 48 years with pheochromocytoma. Ann. Surg. 229, 755–764 (1999) (discussion 764-756).
doi: 10.1097/00000658-199906000-00001
Wachtel, H. et al. Preoperative metyrosine improves cardiovascular outcomes for patients undergoing surgery for pheochromocytoma and paraganglioma. Ann. Surg. Oncol. 22, S646-654 (2015).
doi: 10.1245/s10434-015-4862-z
Cascón, A. et al. Genetics of pheochromocytoma and paraganglioma in Spanish patients. J. Clin. Endocrinol. Metab. 94, 1701–1705 (2009).
doi: 10.1210/jc.2008-2756
Mannelli, M. et al. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J. Clin. Endocrinol. Metab. 94, 1541–1547 (2009).
doi: 10.1210/jc.2008-2419
Neumann, H. P. H. et al. Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy. JAMA Netw. Open 2, e198898 (2019).
doi: 10.1001/jamanetworkopen.2019.8898
Korpershoek, E. et al. Adrenal medullary hyperplasia is a precursor lesion for pheochromocytoma in MEN2 syndrome. Neoplasia 16, 868–873 (2014).
doi: 10.1016/j.neo.2014.09.002
Lloyd, R. V., Osamura, R. Y., Klöppel, G. & Rosai, J. WHO Classification of Tumours of Endocrine Organs 4th edn. (International Agency for Research on Cancer, 2017).
Gomez-Sanchez, C. E. et al. Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol. 383, 111–117 (2014).
doi: 10.1016/j.mce.2013.11.022
Ulaganathan, V. K., Sperl, B., Rapp, U. R. & Ullrich, A. Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site. Nature 528, 570–574 (2015).
doi: 10.1038/nature16449
van Berkel, A. et al. Semiquantitative 123I-metaiodobenzylguanidine scintigraphy to distinguish pheochromocytoma and paraganglioma from physiologic adrenal uptake and its correlation with genotype-dependent expression of catecholamine transporters. J. Nucl. Med. 56, 839–846 (2015).
doi: 10.2967/jnumed.115.154815
Lenders, J. W., Eisenhofer, G., Mannelli, M. & Pacak, K. Phaeochromocytoma. Lancet 366, 665–675 (2005).
doi: 10.1016/S0140-6736(05)67139-5
Kanzawa, M. et al. Adrenal corticomedullary mixed tumor associated with the FGFR4-G388R variant. J. Endocr. Soc. 4, bvaa101 (2020).
doi: 10.1210/jendso/bvaa101
Mate, O. et al. Overview of the 2022 WHO classification of adrenal cortical tumors. Endocr. Pathol. 33(1), 155–196 (2022).
doi: 10.1007/s12022-022-09710-8
Falhammar, H., Stenman, A., Calissendorff, J. & Juhlin, C. C. Presentation, treatment, histology, and outcomes in adrenal medullary hyperplasia compared with pheochromocytoma. J Endocrine Soc. 3, 1518–1530 (2019).
doi: 10.1210/js.2019-00200
Takizawa, N., Muguruma, K. & Sasano, H. Pheochromocytoma and subclinical Cushing’s syndrome with focal adrenocortical hyperplasia. Int. J. Urol. 18, 548–549 (2011).
doi: 10.1111/j.1442-2042.2011.02759.x
Goyal, A., Panchani, R., Varma, T., Bhalla, S. & Tripathi, S. Adrenal incidentaloma: A case of pheochromocytoma with sub-clinical Cushing’s syndrome. Indian J. Endocrinol. Metab. 17, S246-248 (2013).
doi: 10.4103/2230-8210.119587
Edafe, O., Webster, J., Fernando, M., Vinayagam, R. & Balasubramanian, S. P. Phaeochromocytoma with hypercortisolism and hypercalcaemia. BMJ Case Rep. https://doi.org/10.1136/bcr-2014-0208657 (2015).
doi: 10.1136/bcr-2014-0208657
pubmed: 26446319
pmcid: 4600802
Wurtman, R. J. & Axelrod, J. Adrenaline synthesis: control by the pituitary gland and adrenal glucocorticoids. Science 150, 1464–1465 (1965).
doi: 10.1126/science.150.3702.1464
Mezey, E., Reisine, T. D., Palkovits, M., Brownstein, M. J. & Axelrod, J. Direct stimulation of beta 2-adrenergic receptors in rat anterior pituitary induces the release of adrenocorticotropin in vivo. Proc. Natl. Acad. Sci. USA 80, 6728–6731 (1983).
doi: 10.1073/pnas.80.21.6728
Constantinescu, G. et al. Glucocorticoid excess in patients with pheochromocytoma compared with paraganglioma and other forms of hypertension. J. Clin. Endocrinol. Metab. 105, e3374-3383 (2020).
doi: 10.1210/clinem/dgaa423